Als Empfehlung der A.T. Kearney-Service-Experten finden Sie hier eine Auswahl unserer Studien und Monografien für Pharmaindustrie und Gesundheitswesen.
From the vaccines that eradicated small pox and polio to the drugs that have improved cancer and AIDS treatment, the pharmaceutical industry is one of the great success stories in recent history. But as healthcare systems teeter out of balance, so does pharmaceuticals.
The chemical industry is undergoing rapid change. Major players are remaking and updating product portfolios they have pursued for decades. Through recent M&A activity, some companies are increasing their scale and critical mass, while others, such as BASF and Dow, are pursuing new, more customer-focused specialty areas. These changes have prompted many chemical companies to take a fresh look at their organizations—particularly at the growing complexity. Companies that take control of their complexity can release hidden earnings potential, in some cases increasing margins by 2 to 5 percent. Margin improvements like these can mean the difference between success and failure.
Top